BioReperia
Desconocido
EVEREST: Extracellular Vesicle Research Exchanges for Advanced Biomarkers and Therapeutics
The EVEREST project is a pioneering consortium in Extracellular Vesicle (EVs) research, bringing together 22 institutions from 11 countries,...
2024-08-01 - 2028-12-31 | Financiado
2024-08-01 - 2028-12-31 | Financiado
CRYSTAL3: Commercial Research Opportunity for Cysteinyl Leukotriene Signalling in Ocular CNS Dysfunction...
BIOREPERIA AB
participó en un
H2020:
H2020-MSCA-RISE-2020
Cysteinyl leukotrienes (CysLTs) are potent lipid mediators of inflammation. CysLT1 and 2 receptors are widely expressed e.g. lungs, colorect...
2020-10-02 - 2024-12-31 | Financiado
2020-10-02 - 2024-12-31 | Financiado
3D NEONET: Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics
BIOREPERIA AB
participó en un
H2020:
H2020-MSCA-RISE-2016
Severe ocular disorders are affecting the lives of more than 100Mill people world-wide and at least 25% of the population above 70 years of...
2016-11-08 - 2022-06-30 | Financiado
2016-11-08 - 2022-06-30 | Financiado
* No se disponen de datos de la empresa actual.